Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans

Summary Low serum testosterone (T) is common and increasingly prevalent with increased age. Recent studies report an ‘epidemic’ of T prescribing and concern about unnecessary T treatment. We investigated the number of men tested for T, the prevalence of low serum T levels, and initiation of T treatm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Andrology (Oxford) 2015-03, Vol.3 (2), p.287-292
Hauptverfasser: Walsh, T. J., Shores, M. M., Fox, A. E., Moore, K. P., Forsberg, C. W., Kinsey, C. E., Heckbert, S. R., Zeliadt, S., Thompson, M. L., Smith, N. L., Matsumoto, A. M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 292
container_issue 2
container_start_page 287
container_title Andrology (Oxford)
container_volume 3
creator Walsh, T. J.
Shores, M. M.
Fox, A. E.
Moore, K. P.
Forsberg, C. W.
Kinsey, C. E.
Heckbert, S. R.
Zeliadt, S.
Thompson, M. L.
Smith, N. L.
Matsumoto, A. M.
description Summary Low serum testosterone (T) is common and increasingly prevalent with increased age. Recent studies report an ‘epidemic’ of T prescribing and concern about unnecessary T treatment. We investigated the number of men tested for T, the prevalence of low serum T levels, and initiation of T treatment among those with low T levels in men treated at Veterans Affairs (VA) facilities in the Northwest US (VISN 20). We identified male Veterans aged 40–89 years and examined yearly proportions of men tested for T, found to have low T levels (total T 
doi_str_mv 10.1111/andr.12014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1675872102</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1675872102</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4634-85bc7ada7977cf25060284697b84ef2ab63bbdc49dfee4cdad1e3b861316f0a13</originalsourceid><addsrcrecordid>eNp9kV9LwzAUxYMobsy9-AGk4IvIOpM0bdrHMf_CUBjqa0nT29HRJjPpHPv2puscuAcvgSTc3z055CB0SfCYuLoTKjdjQjFhJ6hPMeM-TSg_PZxJ0kNDa5fYVdwueo56NIxiFgVRH5VzkKAarzGgcuuVymvANto2YLSC3aVUi5FX6c3fTgXfUNmR594_GjEgmrrVFLVWC-8TXEMoe4HOClFZGO73Afp4fHifPvuzt6eX6WTmS-eI-XGYSS5ywRPOZUFDHGHqvCY8ixkUVGRRkGW5ZEleADCZi5xAkMURCUhUYEGCAbrpdFdGf62ds7QurYSqEgr02qYk4mHMKcHUoddH6FKvjXLuWoolMeE4dtRtR0mjrTVQpCtT1sJsU4LTNoO0zSDdZeDgq73kOqshP6C_P-4A0gGbsoLtP1Lp5PV-3on-AHy5ktE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1674981708</pqid></control><display><type>article</type><title>Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans</title><source>MEDLINE</source><source>Wiley Journals</source><source>Wiley Online Library (Open Access Collection)</source><creator>Walsh, T. J. ; Shores, M. M. ; Fox, A. E. ; Moore, K. P. ; Forsberg, C. W. ; Kinsey, C. E. ; Heckbert, S. R. ; Zeliadt, S. ; Thompson, M. L. ; Smith, N. L. ; Matsumoto, A. M.</creator><creatorcontrib>Walsh, T. J. ; Shores, M. M. ; Fox, A. E. ; Moore, K. P. ; Forsberg, C. W. ; Kinsey, C. E. ; Heckbert, S. R. ; Zeliadt, S. ; Thompson, M. L. ; Smith, N. L. ; Matsumoto, A. M.</creatorcontrib><description>Summary Low serum testosterone (T) is common and increasingly prevalent with increased age. Recent studies report an ‘epidemic’ of T prescribing and concern about unnecessary T treatment. We investigated the number of men tested for T, the prevalence of low serum T levels, and initiation of T treatment among those with low T levels in men treated at Veterans Affairs (VA) facilities in the Northwest US (VISN 20). We identified male Veterans aged 40–89 years and examined yearly proportions of men tested for T, found to have low T levels (total T &lt; 280 ng/dL, free T &lt; 34 pg/mL, or bioavailable T &lt; 84 ng/dL), and subsequently treated with T from 2002 to 2011. We excluded men who had T treatment in the year prior and men with diagnoses of prostate or breast cancer. Treatment initiation was defined as the first prescription for T within a year following a low T test. From 2002 to 2011, the yearly population of eligible men in VISN 20 increased from 129 247 to 163 572. The proportion of men who had serum T tests increased from 3.2% in 2002 to 5.8% in 2011. Among the tested men, the percentage of men with low T levels increased from 35.0 to 47.3%. However, the proportion of men with low T levels who were given T treatment within a year decreased from 31.0 to 28.0%. Despite large increases in T testing, and detection of men with low T levels, there was a slight decrease in the proportion of men with low T levels who were treated with T. The decrease in T treatment during this time period contrasts with other studies and may be related to higher comorbidity in Veterans and/or VA formulary restrictions on the use of transdermal T formulations.</description><identifier>ISSN: 2047-2919</identifier><identifier>EISSN: 2047-2927</identifier><identifier>DOI: 10.1111/andr.12014</identifier><identifier>PMID: 25684636</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Hormone Replacement Therapy ; Humans ; Male ; Middle Aged ; testosterone ; Testosterone - administration &amp; dosage ; trends ; United States ; Veterans</subject><ispartof>Andrology (Oxford), 2015-03, Vol.3 (2), p.287-292</ispartof><rights>2015 American Society of Andrology and European Academy of Andrology</rights><rights>2015 American Society of Andrology and European Academy of Andrology.</rights><rights>Andrology © 2015 American Society of Andrology and European Academy of Andrology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4634-85bc7ada7977cf25060284697b84ef2ab63bbdc49dfee4cdad1e3b861316f0a13</citedby><cites>FETCH-LOGICAL-c4634-85bc7ada7977cf25060284697b84ef2ab63bbdc49dfee4cdad1e3b861316f0a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fandr.12014$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fandr.12014$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25684636$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Walsh, T. J.</creatorcontrib><creatorcontrib>Shores, M. M.</creatorcontrib><creatorcontrib>Fox, A. E.</creatorcontrib><creatorcontrib>Moore, K. P.</creatorcontrib><creatorcontrib>Forsberg, C. W.</creatorcontrib><creatorcontrib>Kinsey, C. E.</creatorcontrib><creatorcontrib>Heckbert, S. R.</creatorcontrib><creatorcontrib>Zeliadt, S.</creatorcontrib><creatorcontrib>Thompson, M. L.</creatorcontrib><creatorcontrib>Smith, N. L.</creatorcontrib><creatorcontrib>Matsumoto, A. M.</creatorcontrib><title>Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans</title><title>Andrology (Oxford)</title><addtitle>Andrology</addtitle><description>Summary Low serum testosterone (T) is common and increasingly prevalent with increased age. Recent studies report an ‘epidemic’ of T prescribing and concern about unnecessary T treatment. We investigated the number of men tested for T, the prevalence of low serum T levels, and initiation of T treatment among those with low T levels in men treated at Veterans Affairs (VA) facilities in the Northwest US (VISN 20). We identified male Veterans aged 40–89 years and examined yearly proportions of men tested for T, found to have low T levels (total T &lt; 280 ng/dL, free T &lt; 34 pg/mL, or bioavailable T &lt; 84 ng/dL), and subsequently treated with T from 2002 to 2011. We excluded men who had T treatment in the year prior and men with diagnoses of prostate or breast cancer. Treatment initiation was defined as the first prescription for T within a year following a low T test. From 2002 to 2011, the yearly population of eligible men in VISN 20 increased from 129 247 to 163 572. The proportion of men who had serum T tests increased from 3.2% in 2002 to 5.8% in 2011. Among the tested men, the percentage of men with low T levels increased from 35.0 to 47.3%. However, the proportion of men with low T levels who were given T treatment within a year decreased from 31.0 to 28.0%. Despite large increases in T testing, and detection of men with low T levels, there was a slight decrease in the proportion of men with low T levels who were treated with T. The decrease in T treatment during this time period contrasts with other studies and may be related to higher comorbidity in Veterans and/or VA formulary restrictions on the use of transdermal T formulations.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Hormone Replacement Therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>testosterone</subject><subject>Testosterone - administration &amp; dosage</subject><subject>trends</subject><subject>United States</subject><subject>Veterans</subject><issn>2047-2919</issn><issn>2047-2927</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV9LwzAUxYMobsy9-AGk4IvIOpM0bdrHMf_CUBjqa0nT29HRJjPpHPv2puscuAcvgSTc3z055CB0SfCYuLoTKjdjQjFhJ6hPMeM-TSg_PZxJ0kNDa5fYVdwueo56NIxiFgVRH5VzkKAarzGgcuuVymvANto2YLSC3aVUi5FX6c3fTgXfUNmR594_GjEgmrrVFLVWC-8TXEMoe4HOClFZGO73Afp4fHifPvuzt6eX6WTmS-eI-XGYSS5ywRPOZUFDHGHqvCY8ixkUVGRRkGW5ZEleADCZi5xAkMURCUhUYEGCAbrpdFdGf62ds7QurYSqEgr02qYk4mHMKcHUoddH6FKvjXLuWoolMeE4dtRtR0mjrTVQpCtT1sJsU4LTNoO0zSDdZeDgq73kOqshP6C_P-4A0gGbsoLtP1Lp5PV-3on-AHy5ktE</recordid><startdate>201503</startdate><enddate>201503</enddate><creator>Walsh, T. J.</creator><creator>Shores, M. M.</creator><creator>Fox, A. E.</creator><creator>Moore, K. P.</creator><creator>Forsberg, C. W.</creator><creator>Kinsey, C. E.</creator><creator>Heckbert, S. R.</creator><creator>Zeliadt, S.</creator><creator>Thompson, M. L.</creator><creator>Smith, N. L.</creator><creator>Matsumoto, A. M.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201503</creationdate><title>Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans</title><author>Walsh, T. J. ; Shores, M. M. ; Fox, A. E. ; Moore, K. P. ; Forsberg, C. W. ; Kinsey, C. E. ; Heckbert, S. R. ; Zeliadt, S. ; Thompson, M. L. ; Smith, N. L. ; Matsumoto, A. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4634-85bc7ada7977cf25060284697b84ef2ab63bbdc49dfee4cdad1e3b861316f0a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Hormone Replacement Therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>testosterone</topic><topic>Testosterone - administration &amp; dosage</topic><topic>trends</topic><topic>United States</topic><topic>Veterans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Walsh, T. J.</creatorcontrib><creatorcontrib>Shores, M. M.</creatorcontrib><creatorcontrib>Fox, A. E.</creatorcontrib><creatorcontrib>Moore, K. P.</creatorcontrib><creatorcontrib>Forsberg, C. W.</creatorcontrib><creatorcontrib>Kinsey, C. E.</creatorcontrib><creatorcontrib>Heckbert, S. R.</creatorcontrib><creatorcontrib>Zeliadt, S.</creatorcontrib><creatorcontrib>Thompson, M. L.</creatorcontrib><creatorcontrib>Smith, N. L.</creatorcontrib><creatorcontrib>Matsumoto, A. M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Andrology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Walsh, T. J.</au><au>Shores, M. M.</au><au>Fox, A. E.</au><au>Moore, K. P.</au><au>Forsberg, C. W.</au><au>Kinsey, C. E.</au><au>Heckbert, S. R.</au><au>Zeliadt, S.</au><au>Thompson, M. L.</au><au>Smith, N. L.</au><au>Matsumoto, A. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans</atitle><jtitle>Andrology (Oxford)</jtitle><addtitle>Andrology</addtitle><date>2015-03</date><risdate>2015</risdate><volume>3</volume><issue>2</issue><spage>287</spage><epage>292</epage><pages>287-292</pages><issn>2047-2919</issn><eissn>2047-2927</eissn><abstract>Summary Low serum testosterone (T) is common and increasingly prevalent with increased age. Recent studies report an ‘epidemic’ of T prescribing and concern about unnecessary T treatment. We investigated the number of men tested for T, the prevalence of low serum T levels, and initiation of T treatment among those with low T levels in men treated at Veterans Affairs (VA) facilities in the Northwest US (VISN 20). We identified male Veterans aged 40–89 years and examined yearly proportions of men tested for T, found to have low T levels (total T &lt; 280 ng/dL, free T &lt; 34 pg/mL, or bioavailable T &lt; 84 ng/dL), and subsequently treated with T from 2002 to 2011. We excluded men who had T treatment in the year prior and men with diagnoses of prostate or breast cancer. Treatment initiation was defined as the first prescription for T within a year following a low T test. From 2002 to 2011, the yearly population of eligible men in VISN 20 increased from 129 247 to 163 572. The proportion of men who had serum T tests increased from 3.2% in 2002 to 5.8% in 2011. Among the tested men, the percentage of men with low T levels increased from 35.0 to 47.3%. However, the proportion of men with low T levels who were given T treatment within a year decreased from 31.0 to 28.0%. Despite large increases in T testing, and detection of men with low T levels, there was a slight decrease in the proportion of men with low T levels who were treated with T. The decrease in T treatment during this time period contrasts with other studies and may be related to higher comorbidity in Veterans and/or VA formulary restrictions on the use of transdermal T formulations.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>25684636</pmid><doi>10.1111/andr.12014</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2047-2919
ispartof Andrology (Oxford), 2015-03, Vol.3 (2), p.287-292
issn 2047-2919
2047-2927
language eng
recordid cdi_proquest_miscellaneous_1675872102
source MEDLINE; Wiley Journals; Wiley Online Library (Open Access Collection)
subjects Adult
Aged
Aged, 80 and over
Hormone Replacement Therapy
Humans
Male
Middle Aged
testosterone
Testosterone - administration & dosage
trends
United States
Veterans
title Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A00%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20trends%20in%20testosterone%20testing,%20low%20testosterone%20levels,%20and%20testosterone%20treatment%20among%20Veterans&rft.jtitle=Andrology%20(Oxford)&rft.au=Walsh,%20T.%20J.&rft.date=2015-03&rft.volume=3&rft.issue=2&rft.spage=287&rft.epage=292&rft.pages=287-292&rft.issn=2047-2919&rft.eissn=2047-2927&rft_id=info:doi/10.1111/andr.12014&rft_dat=%3Cproquest_cross%3E1675872102%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1674981708&rft_id=info:pmid/25684636&rfr_iscdi=true